IP Library Granted Patent US 9,433,684
Granted Patent B2
US 9,433,684 · App. 12/737,833 · Granted Sep 6, 2016

Conjugates of small-interfering nucleic acids

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,433,684
App. No.
12/737,833
Granted
Sep 6, 2016
Kind
B2
Abstract

The present invention relates to conjugates of small-interfering nucleic acids (siNA). Compositions of siNA suited for administration to a patient are described. Methods for delivering the compositions are also described.

Claims (19)

1. A conjugate comprising a residue of a siNA having a 5′ amino linker with a terminal amino group having the structure

covalently attached at the terminal amino group to a single polymeric reagent having the following structure,

wherein: R 2 is H and each of R 1 and R 3 is

R 2 is H and each of R 1 and R 3 is

R 1 is H, R 2 is

 and R 3 is

R 1 is H, R 2 is

 and R 3 is

where each m-PEG represents CH 3 O(CH 2 CH 2 O) n —CH 2 CH 2 ˜ and (n) is defined to provide CH 3 O(CH 2 CH 2 O) n —CH 2 CH 2 ˜ with a weight-average molecular weight of from 10,000 Daltons to 40,000 Daltons

, and wherein the siNA is selected from the group consisting of double stranded siNA that is blunt ended, double stranded siNA that has a 5′overhang, and double stranded siNA that has a 3′ overhang.

2. The conjugate of claim 1 , wherein the siNA is a siRNA.

3. The conjugate of claim 1 , wherein the siNA has a length of from 10 to 30 nucleotides.

4. The conjugate of claim 1 , wherein the siNA has a length of from 15 to 25 nucleotides.

5. The conjugate of claim 1 , wherein the siNA is double stranded siNA that is blunt ended.

6. The conjugate of claim 1 , wherein the siNA is double stranded siNA that has a 5′overhang.

7. The conjugate of claim 6 , wherein the 5′overhang is an overhang of a number of nucleotides selected from the group consisting of 1, 2, 3 and 4.

8. The conjugate of claim 1 , wherein the siNA is a double stranded siNA that has a 3′overhang.

9. The conjugate of claim 8 , wherein the 3′overhang is an overhang of a number of nucleotides selected from the group consisting of 1, 2, 3 and 4.

10. The conjugate of claim 1 , wherein the siNA includes one or more modified nucleotides selected from the group consisting of 2′O-methyl nucleotides, 2′F nucleotides, 2′deoxynucleotides, 2′OMOE nucleotides, locked nucleic acids and unlocked nucleic acids.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Apr 17, 2020
From: TC LENDING, LLC, AS COLLATERAL AGENT
To: NEKTAR THERAPEUTICS
Reel/Frame 053180/0009 →
RELEASE OF SECURITY INTEREST RECORDED AT REEL 28571, FRAME 0141 Recorded Oct 14, 2015
From: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
To: NEKTAR THERAPEUTICS
Reel/Frame 036866/0700 →
GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS Recorded Oct 6, 2015
From: NEKTAR THERAPEUTICS
To: TC LENDING, LLC, AS COLLATERAL AGENT
Reel/Frame 036796/0562 →
GRANT OF SECURITY INTEREST Recorded Jul 17, 2012
From: NEKTAR THERAPEUTICS
To: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 028571/0141 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 7, 2012
From: MCMANUS, SAMUEL P.; RILEY, TIMOTHY A.; CULBERTSON, SEAN M.; KOZLOWSKI, ANTONI; FRY, DENNIS G.; YUAN, XUEJUN; SHENG, DAWEI; DIXIT, VIDULA R.
To: NEKTAR THERAPEUTICS
Reel/Frame 027821/0280 →